Overview

Observational Study on the Weight Effect of Insulin Detemir (LevemirĀ®) in Type 2 Diabetics

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. Observational study evaluating the body weight progress during the treatment with insulin detemir (LevemirĀ®) in Type 2 patients, previously treated with other basal insulins
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Insulin
Insulin Detemir
Insulin, Globin Zinc